'Dhurandhar 2' OTT release: Ranveer Singh and Aditya Dhar film titled 'Dhurandhar The Revenge (Raw and Undekha)'; gears up for streaming debut on May 15 |

‘Dhurandhar 2’ OTT release: Ranveer Singh and Aditya Dhar film titled ‘Dhurandhar The Revenge (Raw and Undekha)’; gears up for streaming debut on May 15 |

After a historic run at the Indian box office, ‘Dhurandhar 2: The Revenge’ is now gearing up for its digital premiere.Ahead of the big reveal by the streaming giants, fans of the Ranveer Singh starrer, directed by Aditya Dhar, took to social media to share screenshots of the film’s title card allegedly listed on OTT…

Read More
Top residential hotspots emerging along India's new metro corridors

Top residential hotspots emerging along India’s new metro corridors

Metro infrastructure does more than improve transportation. It influences where people choose to live, work, and invest. Reduced commuting time improves quality of life, while better connectivity often attracts commercial establishments, educational institutions, healthcare facilities, and retail developments. As a result, areas surrounding metro stations frequently experience rising demand, improved infrastructure, and stronger property value…

Read More
APPGECET 2026 results declared; 93.29 per cent candidates qualify for engineering and pharmacy PG admissions

APPGECET 2026 results declared; 93.29 per cent candidates qualify for engineering and pharmacy PG admissions

APPGECET 2026 results: Andhra University has released the APPGECET 2026 results for admissions to postgraduate engineering, pharmacy and technology courses in Andhra Pradesh. The Andhra Pradesh State Council of Higher Education entrusted the university with conducting the examination this year. Results and rank cards have been made available on the official portal.A total of 12,102…

Read More
Gujarat Themis Biosyn to acquire Japan’s MicroBiopharm for ₹1,300 crore

Gujarat Themis Biosyn to acquire Japan’s MicroBiopharm for ₹1,300 crore

Gujarat Themis Biosyn Ltd (GTBL) on Friday (May 22) said it has entered into a definitive agreement to acquire 100% equity shareholding of Japan-based MicroBiopharm Japan Co, Ltd (MBJ) through Themis Biosyn Japan Ltd, its wholly-owned subsidiary incorporated in Japan. The acquisition, subject to regulatory approvals and customary closing formalities, will be completed for a…

Read More